Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade 2024-03-29 06:00
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Keosaa Launches Debut Electric Toothbrush on Amazon for Enhanced Oral Care 2024-03-28 21:00
Primech Holdings Limited Provides Financial Updates and Corporate Highlights For the Six Months Ended September 30, 2023 2024-03-28 20:30
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
Tigermed Reports Full Year 2023 Results 2024-03-28 18:31
Ascentage Pharma Announces 2023 Annual Results 2024-03-27 22:30
CARsgen Announced 2023 Annual Results 2024-03-27 20:50
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean 2024-03-27 20:00
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
Waterdrop declared a special cash dividend, the aggregate payment of which amounted to approximately US$15 million 2024-03-27 14:35
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology 2024-03-27 06:00
Keymed Biosciences Announces 2023 Annual Results and Business Updates 2024-03-27 01:16
Datasea Enters into 5G AI Multimodal Communication Cooperation Agreement Expected to Expand its China 5G Services Revenue 2024-03-26 22:00
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients 2024-03-26 21:00
TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients 2024-03-26 20:00
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition 2024-03-26 20:00
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results and a Special Cash Dividend 2024-03-26 18:00
Full-Life Technologies Achieves Regulatory Milestone with Nuclear Permit, Advancing Radioisotope Facility Construction 2024-03-26 08:00
1 42 43 44 45 46 800